Vise Technologies’s Integra LifeSciences IART Stock Holding History

Vise Technologies’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-9,371	Closed	-$273K	–	601
2024 Q2	$273K	Sell	9,371 -2,656	-22%	-$78.8K	0.05%	333
2024 Q1	$426K	Sell	12,027 -1,499	-11%	-$60K	0.08%	231
2023 Q4	$589K	Buy	13,526 +1,451	+12%	+$57.1K	0.13%	165
2023 Q3	$461K	Buy	+12,075	New	+$508K	0.11%	182
2023 Q1	–	Sell	-7,096	Closed	-$398K	–	350
2022 Q4	$398K	Sell	7,096 -119	-2%	-$6.06K	0.12%	183
2022 Q3	$306K	Buy	+7,215	New	+$370K	0.12%	204

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vise Technologies's IART Position: Q3 2024 in Review

Vise Technologies sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 9,371 shares — an estimated $273K sold.

Vise Technologies first reported a position in IART in Q3 2022 and held it in 6 quarters. The position peaked at $589K in Q4 2023. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

Vise Technologies reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
Vise Technologies sold 9,371 Integra LifeSciences shares in Q3 2024, an estimated $273K.
Vise Technologies first reported a position in Integra LifeSciences in Q3 2022 and held it in 6 quarters.
Vise Technologies's Integra LifeSciences position peaked at $589K in Q4 2023.
225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Vise Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.